(Q33832037)

29 July 2017

An overview of the different excipients useful for the direct compression of tablets (English)

1 reference

29 July 2017

Jivraj I I

1

1 reference

PubMed ID

10664574

29 July 2017

Martini LG

series ordinal

2

1 reference

PubMed ID

10664574

29 July 2017

Thomson CM

series ordinal

3

1 reference

29 July 2017

1 February 2000

1 reference

Pharmaceutical science & technology today

29 July 2017

1 reference

29 July 2017

3

1 reference

29 July 2017

2

1 reference

29 July 2017

58-63

1 reference

Effect of particle size on the compaction mechanism and tensile strength of tablets

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

The effect of the relationship between punch velocity and particle size on the compaction behaviour of materials with varying deformation mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Contact angles and wetting of pharmaceutical powders

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Effect of variation in compaction force on properties of six direct compression tablet formulations

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Effect of Moisture on Physical Characteristics of Tablets Prepared from Direct Compression Excipients

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Pharmaceutical development of tablets of a new antineoplastic drug: mitonafide

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Excipients as stabilizers

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

Selection of solid dosage form composition through drug-excipient compatibility testing

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900237-0

7 January 2021

10.1016/S1461-5347(99)00237-0

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10664574